[go: up one dir, main page]

EP3686266B1 - Synbiotic surface treatment composition - Google Patents

Synbiotic surface treatment composition Download PDF

Info

Publication number
EP3686266B1
EP3686266B1 EP19153404.9A EP19153404A EP3686266B1 EP 3686266 B1 EP3686266 B1 EP 3686266B1 EP 19153404 A EP19153404 A EP 19153404A EP 3686266 B1 EP3686266 B1 EP 3686266B1
Authority
EP
European Patent Office
Prior art keywords
composition
bacillus
spores
probiotic
prebiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP19153404.9A
Other languages
German (de)
French (fr)
Other versions
EP3686266A1 (en
Inventor
Corrie GIELEN
Robin Temmerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heiq Chrisal NV
Original Assignee
Heiq Chrisal NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65493788&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP3686266(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to HUE19153404A priority Critical patent/HUE069638T2/en
Priority to EP19153404.9A priority patent/EP3686266B1/en
Priority to PL19153404.9T priority patent/PL3686266T3/en
Priority to ES19153404T priority patent/ES3000886T3/en
Priority to PT191534049T priority patent/PT3686266T/en
Application filed by Heiq Chrisal NV filed Critical Heiq Chrisal NV
Priority to BE20205048A priority patent/BE1026988B1/en
Publication of EP3686266A1 publication Critical patent/EP3686266A1/en
Publication of EP3686266B1 publication Critical patent/EP3686266B1/en
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/22Carbohydrates or derivatives thereof
    • C11D3/222Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/38Products with no well-defined composition, e.g. natural products
    • C11D3/381Microorganisms

Definitions

  • the present invention relates to methods for treating surfaces with compositions containing at least one prebiotic component and a probiotic component.
  • WO 2006/125283 teaches that the colonizing of surfaces with non-pathogenic spore-forming bacteria via cleaning products has a favourable effect in reducing the number of pathogenic microorganisms on such surfaces. This decreases the risk of infections and has a beneficial effect on general health.
  • compositions furthermore should be applicable to surfaces which are hard to treat, such as surfaces which are positioned in such a way that they are hard to reach via conventional cleaning techniques and/or surfaces which are situated in environmental conditions which make them hard to treat.
  • European patent application publication no. EP 3 210 612 A1 of the present applicant discloses a method for the treatment of intact or damaged human and animal skin, tissue and wounds with a synbiotic preparation, comprising a mixture with a combination of non-pathogenic spore-forming bacteria, prebiotic sugars, and optionally microcapsules.
  • the spores of the non-pathogenic spore-forming bacteria germinate on the skin or in the tissue or wound in order to inhibit the growth of other microorganisms.
  • the prebiotic sugars stimulate the activity of non-pathogenic microorganisms.
  • the microcapsules provide prolonged release of additional non-pathogenic microorganisms and prebiotic sugars.
  • International patent application publication no. WO 2016/022779 A1 discloses a plant or plant part coated with a composition comprising a bacterial spore and a germinative compound.
  • that disclosure is directed to a method of enhancing the growth of a plant or plant part comprising coating such plant or plant part with such a composition.
  • that disclosure is directed to a composition comprising a bacterial spore and a germinative compound where such components are maintained in an inactive form. That disclosure also relates to use of the compositions in wastewater treatment, environmental remediation, oil recovery, aquaculture systems, and direct fed microbials.
  • European patent publication EP 0 245 560 B1 discloses a cleaning composition comprising a stable suspension of abrasive particles and viable microorganisms in a water solution containing a detergent.
  • United States patent application publication no. US 2004/191232 A1 discloses compositions and methods for inhibiting microbial infections associated with the use of sanitary products, such as diapers, bandages, sanitary napkins, tampons and the like.
  • the disclosure comprises providing for use a sanitary product containing an effective amount of a viable non-pathogenic lactic-acid bacteria, such as Bacillus coagulans, or an extracellular product thereof, useful for inhibiting growth of parasites and pathogens on the epithelial tissue in contact with the sanitary product during use of the product.
  • the disclosure also provides for enhancing biodegradation of sanitary products after use and disposal. Also described are methods using the product and systems containing the compositions.
  • United States patent no. US 6,387,874 B1 discloses an aqueous cleaning composition comprising: an effective mineral dissolving amount of an organic acid of at least 5% by weight of the cleaning compositions; an effective amount of a spore forming microbial composition; an effective cleaning amount of a blend of wetting agents, the first wetting agent having a hydrophobic/lipophobic number (HLB) of about 10 and higher and a second wetting agent having an HLB number of about 5 or less; an effective amount of a thickening agent and water.
  • the composition is also available in powder form without the thickening agent.
  • a method for treating surfaces with a surface treatment composition comprising spores of non-pathogenic species of the genus Bacillus and a prebiotic component, in accordance with claim 1.
  • surfaces can be substantially purified of pathogenic micro-organisms by inoculating said surfaces with said composition.
  • the non-pathogenic probiotics have as an effect that nutrients on the surface become less available for other micro-organisms through the mechanism of nutrient depletion. It has thereby been advantageously been found that the combination of non-pathogenic probiotics with a prebiotic component further amplifies this effect.
  • a further advantage is that both probiotic and prebiotic components place a lighter burden on the environment, in comparison with other compounds used in detergents, such as alcohols etc. It is a further advantage that said composition can be used in products for the purification of surfaces, said products having a shelf life of at least three years.
  • each of the selected Bacillus spp. are non-pathogenic microorganisms.
  • the selected Bacillus spp. have different germination rates.
  • said Bacillus spp. will have a different concentration profile in time, thereby ensuring a constant presence of a probiotic component on the surface.
  • said selection results in an optimized diversity of extracellular enzymes. It is a further advantage that said presence of probiotic components on the surface can be guaranteed when each of said four Bacillus species has a number of spores which is between 10 % and 70 %, with reference to the total number of spores of said four Bacillus spp.
  • the presence of a prebiotic sugar further amplifies the effect of the probiotic component. More in particular, it has been found that said prebiotic component accelerates in time the activity of the probiotic component and that a combination of a probiotic component and a prebiotic component according to the invention reduces even further the concentration of pathogens.
  • said at least one non-pathogenic species is present in a concentration of 1 ⁇ 10 6 to 1 ⁇ 10 10 cfu per gram composition.
  • said concentration range allows both treating surfaces by use of a detergent or cleaning product comprising said composition, as well as treating surfaces by water dosing, wherein products for the latter typically have an initially higher cfu concentration per gram composition due to the fact that these products tend to be diluted upon use.
  • said prebiotic component is present in a concentration of 100 mg to 100 g per kg composition.
  • said spores of at least one species and said prebiotic component are at least partly encapsulated in microcapsules.
  • microcapsules further allows to spread germination in time, thereby ensuring a constant presence and a persistent activity of Bacillus spp. on the treated surface.
  • said microcapsule comprises a brittle shell and is furthermore filled with a non-aqueous solution.
  • the diameter of the microcapsules is 1 to 300 ⁇ m.
  • said composition is formulated as a detergent, cleaning product, liquid, emulsion, cream, ointment, lotion, gel, oil, solution, trigger spray, aerosol spray, powder, or semi-solid formulation.
  • said composition can be used as part of or formulated as the above-mentioned products, thereby increasing the field of application of the composition.
  • said products typically have a shelf life of at least three years.
  • said composition can be applied on a variety of surfaces, which are typically abiotic. However, with the exception of human or animal skin, said composition can also be applied on some biotic materials.
  • the invention described herein refers to a method for treating surfaces with a surface treatment composition, as defined in claim 1.
  • composition used in the method according to claim 1 is a composition for the treatment of surfaces of non-living things.
  • non-living thing can also refer to that which used to be part of a living thing, such as wood, rubber, paper and the like.
  • surface does not refer herein to the surface of living beings, thereby excluding human skin, animal skin or fur and the like.
  • the surface is wood, paper, leathei rubber or textile; or the surface is an abiotic material, such as stone, metal (and alloys thereof), plastic and other polymeric materials, glass, ceramic materials, bricks and the like.
  • said surface can be a surface of composite material, the term "composite material” referring herein to material made from two or more constituent materials. Said surface can further be a mixture of the aforementioned materials.
  • said surface can relate to a surface which is exposed to air, or which is partially or completely submerged in water or in another liquid.
  • the term "surface treatment” refers herein to acting on a surface with the purpose of improving or altering a condition or parameter of said surface.
  • a specific application of embodiments of the invention is for the purpose of purification of the surface, meaning the reduction of unwanted, harmful or pathogenic microorganisms on the surface, such as bacteria, fungi, yeasts, viruses and the like.
  • the surface treatment comprises the act of cleaning the surface with said composition, or applying said composition to said surface through the act of spraying ultrasound fogging, painting or water dosing.
  • water dosing refers herein to the purification of surfaces in installations and/or surfaces of components thereof by addition of said composition to a liquid, such as a cooling liquid, a rinsing liquid or a circulating liquid, wherein said liquid is in contact with the surface to be treated.
  • a liquid such as a cooling liquid, a rinsing liquid or a circulating liquid
  • Said composition may thus be added to the liquid which is in contact with said surface.
  • the term “synbiotic” refers to a combination of a probiotic and a prebiotic.
  • the prebiotic contains one or more from the group consisting of galacto-oligosaccharides, fructo-oligosaccharides and inulin.
  • the prebiotic is inulin.
  • the prebiotic component has a mass fraction which is at least 0.5 mg, preferably at least 1 mg, more preferably at least 10 mg, even more preferably at least 100 mg, and most preferably at least 1g, per kg of the composition. It will be understood that the prebiotic component has a mass fraction which is at most 300 g, preferably at most 200 g, more preferably at most 100 g and most preferably at most 80 g, per kg of the composition.
  • probiotic or “probiotic component” refers to spores of at least one non-pathogenic species of the genus Bacillus.
  • the probiotic component comprises a mixture of spores of Bacillus subtilis, Bacillus licheniformis, Bacillus megaterium and Bacillus amyloliquefaciens.
  • Bacillus subtilis Bacillus subtilis
  • Bacillus licheniformis Bacillus megaterium
  • Bacillus amyloliquefaciens each of said four Bacillus species has a number of spores which is at least 10%, preferably at least 15%, and more preferably at least 20%, with reference to the total number of spores of said four Bacillus spp. in the mixture.
  • Each of said four Bacillus species has a number of spores which is at most 70%, preferably at most 60%, more preferably at most 60%, even more preferably at most 50%, preferably at most 40%, more preferably at most 35%, and most preferably at most 30%, with reference to the total number of spores of said four Bacillus spp. in the mixture.
  • spores of said four species are present in substantially or exactly equal amounts in the mixture.
  • said mixture further comprises Bacillus polymyxa.
  • said mixture does not comprise Bacillus coagulans.
  • the total amount of spores in said aforementioned mixtures ranges from 1 ⁇ 10 6 to 1 ⁇ 10 10 per gram of the composition.
  • Such an amount is expressed as cfu (colony-forming units). It is thereby understood that this value refers to the total number of cfu of all the Bacillus spp. together.
  • the probiotic component is a mixture consisting of spores of Bacillus subtilis, Bacillus licheniformis, Bacillus megaterium and Bacillus amyloliquefaciens.
  • the transformation of spores to vegetative cells is the result of absorption of moisture from the surrounding surface or from the biofilm to which the preparation is applied [ Knudsen et al. (2015) J. Bacteriol. 19;198(1): 168-77 ].
  • This moisture absorption decreases the absolute moisture content of the surface or biofilm, thus exerting an inhibitory action on moisture availability to other microorganisms.
  • the vegetative Bacillus cells produce a variety of extracellular enzymes on surfaces and in biofilm that reduce the amount of organic nutrients on the surface and in biofilm [ Priest (1977) Bacteriol. Rev. 41(3): 711-53 ]. This reduction exerts an inhibitory action on the food availability to other microorganisms via nutrient depletion and the general concept of competitive exclusion [ Ragione et al. (2003) Vet. Microbiol. 94(3): 245-56 ].
  • Treating a surface with a surface treatment composition containing a probiotic component can affect the concentration of unwanted and potentially harmful microorganisms.
  • Such an effect is further optimized by the selection of a mixture the aforementioned four Bacillus spp., i.e. Bacillus subtilis, Bacillus licheniformis, Bacillus megaterium and Bacillus amyloliquefaciens.
  • Bacillus spp. have a different rate in germination, therefore also a different concentration distribution over time, a constant presence of the probiotic component on the surface to be treated is assured. Said selection will result in an even more pronounced moisture depletion as well as an optimized diversity of extracellular enzymes.
  • the combination of a probiotic component and a prebiotic component reduces even further the concentration of pathogens on the treated surface, resulting in a lower concentration of pathogens on the treated surface in comparison with a similar treatment for such a surface without the prebiotic component.
  • the synbiotic surface treatment composition can be used to purify a surface from organic dirt, which may be in the form of a biofilm matrix, as well as to lower the number of other microorganisms such bacteria, viruses, yeasts and fungi. It has been found that the combination of prebiotics with probiotics strengthen the purifying effect of the composition, the prebiotic component thereby seemingly supporting and strengthening the effect of the probiotics on biofilm removal and lowering other micro-organisms.
  • the spores of said probiotic component and said at least one prebiotic component are at least partly encapsulated in microcapsules.
  • microcapsules are particles containing a prebiotic and/or a probiotic. Such capsules are described in US 20120076864 .
  • the composition can be encapsulated in such microcapsules to provide the composition with longer stability/shelf life.
  • said microcapsules may provide for a delayed release of a second part of the probiotic and prebiotic components on the surface or in biofilm. As a result thereof, a persistent activity of the composition for up to 6 weeks can be obtained, provided that sufficient friction is present.
  • the preparation is thereby applied to a surface that suffers from friction (such as human or animal activity (walking, touching) or mechanical activity (interaction with machines or vehicles and the like)), the presence of the microcapsules is an established way of ensuring that the preparation exerts a lasting action.
  • friction such as human or animal activity (walking, touching) or mechanical activity (interaction with machines or vehicles and the like)
  • microcapsules in the composition for the treatment of a surface where frequent treatment of the surface is not possible.
  • the microcapsules are composed of a brittle shell comprising a liquid containing the spores. Said shell breaks open due to friction and releases the contents of the capsule.
  • the microcapsules are typically 1 to 300 ⁇ m in diameter.
  • the shell is composed of a polymer layer, such as a polymer of gelatin, polyurethane, polyolefins, polyamides, polyesters, polysaccharides, silicone resins, epoxy resins, chitosan and aminoplastic resins such as a melamine formaldehyde resin.
  • a polymer layer such as a polymer of gelatin, polyurethane, polyolefins, polyamides, polyesters, polysaccharides, silicone resins, epoxy resins, chitosan and aminoplastic resins such as a melamine formaldehyde resin.
  • said probiotic and prebiotic components may be present together or separately in a microcapsule.
  • said microcapsules may also be provided containing individual bacterial strains.
  • the liquid in the capsules is typically non-aqueous, and more specifically is immiscible with water (e.g. an organic oil, a silicone oil, a fluorocarbon, or mixtures thereof).
  • water e.g. an organic oil, a silicone oil, a fluorocarbon, or mixtures thereof.
  • the weight ratio of the shell to the liquid contained therein is typically 1:500 to 1:5000.
  • the outer layer of this shell can contain functional reactive groups for chemical binding.
  • microcapsules up to 10 wt%, 20 wt%, 30 wt%, 50 wt%, or even 75 wt% of the prebiotic and/or probiotic component may be encapsulated in the microcapsules.
  • Microcapsules may be dispersed in a liquid or viscous composition.
  • the composition is processed into cleaning products (detergents), or products for spraying, for (ultrasound) fogging, for painting or for water dosing.
  • cleaning products detergents
  • products for spraying for (ultrasound) fogging, for painting or for water dosing.
  • Such products are typically in liquid form.
  • the composition may be used as a component in or formulated as: a detergent, a cleaning product, a liquid, an emulsion, a cream, an ointment, a lotion, a gel, an oil, a solution, a trigger spray, an aerosol spray, a powder, or a semi-solid formulation.
  • said composition can be processed in a product for fogging, preferably ultrasound fogging, and combined with a fogging device.
  • An ultrasound fogging device refers herein to a device that uses high-frequency sound vibrations to produce an extra fine water mist that is then expelled to add moisture to the room. It has been found that such an application allows surface treatment of surfaces that cannot be reached by conventional cleaning techniques or that cannot be treated by means of water dosing.
  • water droplets have an average diameter ranging from 0.5 to 10 ⁇ m. It was found that under these conditions, the composition could be maximally distributed into an available space.
  • Example 1 (E1) - Composition of a synbiotic preparation
  • the surface treatment composition has the following components, per gram of the preparation:
  • the surface treatment composition has the following components, per gram of the preparation:
  • Example 1 A sample of Example 1 (E1) and a sample of Comparative Example 2 (CE2) were each diluted in water at a 1:100 dilution ratio and then allowed to germinate.
  • Figure 1 shows the germination speed of both samples.
  • Example 4 Comparative Examples 5-6 (CE5-CE6) - Cleaning product
  • Table 1 An all-purpose cleaning product was defined, having one of the following compositions, as summarized in Table 1: Table 1 - compositions cleaning product Component E4 CE5 CE6 Water 91,8 91,8 91,8 Sodium Laureth Sulphate 5,5 5,5 5,5 Probiotic Mixture 1 1 0 Phenoxyethanol 0,45 0,45 0,45 Inulin 0,5 0 0 Galacto-oligosaccharide 0,25 0 0 Fructo-oligosaccharide 0,15 0 0 CI 42051 0,05 0,05 0,05 Fragrance 0,3 0,3 0,3 Ethanol 0 0 0 Total weight (g) 100 99,1 98,1 wherein said components of said cleaning product are expressed in weight and wherein said Probiotic Mixture is an aqueous mixture of Bacillus subtilis, Bacillus licheniformis, Bacillus megaterium and Bacillus amyloliquefaciens. Each component of said probiotic mixture is present in a concentration of 2 ⁇ 10 9
  • Cleaning products according to the composition E4 and CE5 were used to clean stone tile floors of toilets of a confined experimental space under controlled conditions.
  • the stone tile floors were suffering from severe organic pollution and biofilm, mainly in the concrete joints between the tiles.
  • a picture of a stone tile floor before the treatment is shown in Fig. 2A .
  • a first of such floors was cleaned with an all-purpose cleaning product having a composition according to CE5.
  • a second of said stone tile floors was cleaned with an all-purpose cleaning product having a composition according to E4, being a synbiotic composition.
  • Said first and second floor were then cleaned on a daily basis for a period of three weeks, with said cleaning product on the basis of CE5 and E4 respectively.
  • Fig 2B shows the result after three weeks of daily cleaning with the (probiotic) cleaning product having a composition according to CE5.
  • the probiotic cleaning product was capable of removing superficial biofilm on the tiles surface and partly in the joints.
  • Fig. 2C shows the result after three weeks of daily cleaning with the (synbiotic) E4 cleaning product.
  • the synbiotic cleaning product was capable of removing much more organic dirt and biofilm deep into the joints between the tiles, making them bright again at most places, indicating that the addition of a prebiotic component to a probiotic cleaning product has an unexpected invigorative effect.
  • composition E4 synthetic composition
  • CE5 probiotic composition
  • CE6 forming a diluted detergent
  • the synbiotic preparation as described in E1 was diluted tenfold in water containing 0,1 wt% of Sodium Laureth Sulphate. The dilution was subsequently introduced in an ultrasound fogging device. A Bionaire ® BUL9500B-U Warm and Cool Mist Ultrasonic Humidifier device, a commercially available air humidifier, was therefore used.
  • a fog with particles having a diameter being predominantly between 0.8 ⁇ m and 10 ⁇ m was generated.
  • the device was placed in one corner of a 120m 3 room and sprayed every 15 minutes for 20 seconds, with an output of 1ml of synbiotic solution per minute.
  • Nutrient agar plates were placed on a table at the other side of the room, with open covers. Every 15 minutes, after each fogging, one nutrient agar plate was closed and incubated. A probiotic count was as such determined at starting point ( Fig. 4A ) and after 15 ( Fig. 4B ), 30 ( Fig. 4C ) and 60 ( Fig. 4D ) minutes.
  • a high probiotic count was measured already after 30 minutes, indicating that ultrasound fogging is a very effective distribution of probiotics through the air.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

    Field of the invention
  • The present invention relates to methods for treating surfaces with compositions containing at least one prebiotic component and a probiotic component.
  • Introduction
  • It is known that in some cases, traditional cleaning products and methods are not sufficient or efficient enough. In e.g. hospitals, equipment such as furniture, floors, patient beds and mattresses require regular and thorough cleaning to reduce the number of pathogenic microorganisms which may affect the health of recovering patients. Furthermore, for obvious reasons, shared facilities, such as industrial kitchens or HVAC installations, and their components as well as industrial facilities and components, such as filters, pumps and ducts, also need a permanent reduction and control of such pathogenic populations.
  • It is known that probiotics can be used in combating these harmful bacteria. WO 2006/125283 teaches that the colonizing of surfaces with non-pathogenic spore-forming bacteria via cleaning products has a favourable effect in reducing the number of pathogenic microorganisms on such surfaces. This decreases the risk of infections and has a beneficial effect on general health.
  • However, in view of the growing resistance of some bacterial strains against certain cleaning products, it is important to reduce the numbers of such pathogens as much as possible. There is therefore a need for products and methods that can reduce any unwanted, harmful or pathogenic microorganisms on a surface to a minimum.
  • Such compositions furthermore should be applicable to surfaces which are hard to treat, such as surfaces which are positioned in such a way that they are hard to reach via conventional cleaning techniques and/or surfaces which are situated in environmental conditions which make them hard to treat.
  • European patent application publication no. EP 3 210 612 A1 of the present applicant discloses a method for the treatment of intact or damaged human and animal skin, tissue and wounds with a synbiotic preparation, comprising a mixture with a combination of non-pathogenic spore-forming bacteria, prebiotic sugars, and optionally microcapsules. The spores of the non-pathogenic spore-forming bacteria germinate on the skin or in the tissue or wound in order to inhibit the growth of other microorganisms. The prebiotic sugars stimulate the activity of non-pathogenic microorganisms. The microcapsules provide prolonged release of additional non-pathogenic microorganisms and prebiotic sugars.
  • International patent application publication no. WO 2016/022779 A1 discloses a plant or plant part coated with a composition comprising a bacterial spore and a germinative compound. In another aspect, that disclosure is directed to a method of enhancing the growth of a plant or plant part comprising coating such plant or plant part with such a composition. In yet another aspect, that disclosure is directed to a composition comprising a bacterial spore and a germinative compound where such components are maintained in an inactive form. That disclosure also relates to use of the compositions in wastewater treatment, environmental remediation, oil recovery, aquaculture systems, and direct fed microbials.
  • European patent publication EP 0 245 560 B1 discloses a cleaning composition comprising a stable suspension of abrasive particles and viable microorganisms in a water solution containing a detergent.
  • United States patent application publication no. US 2004/191232 A1 discloses compositions and methods for inhibiting microbial infections associated with the use of sanitary products, such as diapers, bandages, sanitary napkins, tampons and the like. The disclosure comprises providing for use a sanitary product containing an effective amount of a viable non-pathogenic lactic-acid bacteria, such as Bacillus coagulans, or an extracellular product thereof, useful for inhibiting growth of parasites and pathogens on the epithelial tissue in contact with the sanitary product during use of the product. The disclosure also provides for enhancing biodegradation of sanitary products after use and disposal. Also described are methods using the product and systems containing the compositions.
  • United States patent no. US 6,387,874 B1 discloses an aqueous cleaning composition comprising: an effective mineral dissolving amount of an organic acid of at least 5% by weight of the cleaning compositions; an effective amount of a spore forming microbial composition; an effective cleaning amount of a blend of wetting agents, the first wetting agent having a hydrophobic/lipophobic number (HLB) of about 10 and higher and a second wetting agent having an HLB number of about 5 or less; an effective amount of a thickening agent and water. The composition is also available in powder form without the thickening agent.
  • Summary of the invention
  • According to an aspect of the present invention, there is provided a method for treating surfaces with a surface treatment composition, said composition comprising spores of non-pathogenic species of the genus Bacillus and a prebiotic component, in accordance with claim 1.
  • It is an advantage of the present invention that surfaces can be substantially purified of pathogenic micro-organisms by inoculating said surfaces with said composition. The non-pathogenic probiotics have as an effect that nutrients on the surface become less available for other micro-organisms through the mechanism of nutrient depletion. It has thereby been advantageously been found that the combination of non-pathogenic probiotics with a prebiotic component further amplifies this effect. A further advantage is that both probiotic and prebiotic components place a lighter burden on the environment, in comparison with other compounds used in detergents, such as alcohols etc. It is a further advantage that said composition can be used in products for the purification of surfaces, said products having a shelf life of at least three years.
  • It is an advantage of the invention that each of the selected Bacillus spp. are non-pathogenic microorganisms.
  • It is an advantage of the invention that the selected Bacillus spp. have different germination rates. As a result, said Bacillus spp. will have a different concentration profile in time, thereby ensuring a constant presence of a probiotic component on the surface. Furthermore, said selection results in an optimized diversity of extracellular enzymes. It is a further advantage that said presence of probiotic components on the surface can be guaranteed when each of said four Bacillus species has a number of spores which is between 10 % and 70 %, with reference to the total number of spores of said four Bacillus spp.
  • It is an advantage of the invention that the presence of a prebiotic sugar further amplifies the effect of the probiotic component. More in particular, it has been found that said prebiotic component accelerates in time the activity of the probiotic component and that a combination of a probiotic component and a prebiotic component according to the invention reduces even further the concentration of pathogens.
  • In an embodiment of the method according to the present invention, said at least one non-pathogenic species is present in a concentration of 1 × 106 to 1 × 1010 cfu per gram composition.
  • It is an advantage of this embodiment that said concentration range allows both treating surfaces by use of a detergent or cleaning product comprising said composition, as well as treating surfaces by water dosing, wherein products for the latter typically have an initially higher cfu concentration per gram composition due to the fact that these products tend to be diluted upon use.
  • In an embodiment of the method according to the present invention, said prebiotic component is present in a concentration of 100 mg to 100 g per kg composition.
  • It is an advantage of this embodiment that said amplifying effect on the probiotic component is thereby maximized.
  • In an embodiment of the method according to the present invention, said spores of at least one species and said prebiotic component are at least partly encapsulated in microcapsules.
  • It is an advantage of this embodiment that the use of microcapsules further allows to spread germination in time, thereby ensuring a constant presence and a persistent activity of Bacillus spp. on the treated surface.
  • In an embodiment of the method according to the present invention, said microcapsule comprises a brittle shell and is furthermore filled with a non-aqueous solution.
  • In an embodiment of the method according to the present invention, the diameter of the microcapsules is 1 to 300 µm.
  • In an embodiment of the method according to the present invention, said composition is formulated as a detergent, cleaning product, liquid, emulsion, cream, ointment, lotion, gel, oil, solution, trigger spray, aerosol spray, powder, or semi-solid formulation.
  • It is an advantage of this embodiment that said composition can be used as part of or formulated as the above-mentioned products, thereby increasing the field of application of the composition. Advantageously, said products typically have a shelf life of at least three years.
  • It is an advantage of the inveniton that said composition can be applied on a variety of surfaces, which are typically abiotic. However, with the exception of human or animal skin, said composition can also be applied on some biotic materials.
  • Brief description of the figures
    • Figure 1 shows the germination speed of probiotic and synbiotic compositions as a function of time.
    • Figures 2A-2C show the effect of two cleaning products on a stone tile floor.
    • Figure 3 shows the effect of cleaning products on the count of Staphylococcus aureus populations.
    • Figures 4A-4D show the effect in time of ultrasound fogging of a synbiotic preparation by use of probiotic counts
    Detailed Description of Embodiments
  • The invention described herein refers to a method for treating surfaces with a surface treatment composition, as defined in claim 1.
  • The composition used in the method according to claim 1 is a composition for the treatment of surfaces of non-living things. It is thereby noted that the term "non-living thing" can also refer to that which used to be part of a living thing, such as wood, rubber, paper and the like. However, the term "surface" does not refer herein to the surface of living beings, thereby excluding human skin, animal skin or fur and the like.
  • The surface is wood, paper, leathei rubber or textile; or the surface is an abiotic material, such as stone, metal (and alloys thereof), plastic and other polymeric materials, glass, ceramic materials, bricks and the like. Furthermore, said surface can be a surface of composite material, the term "composite material" referring herein to material made from two or more constituent materials. Said surface can further be a mixture of the aforementioned materials.
  • According to embodiments, said surface can relate to a surface which is exposed to air, or which is partially or completely submerged in water or in another liquid.
  • For the purpose of the invention, the term "surface treatment" refers herein to acting on a surface with the purpose of improving or altering a condition or parameter of said surface. A specific application of embodiments of the invention is for the purpose of purification of the surface, meaning the reduction of unwanted, harmful or pathogenic microorganisms on the surface, such as bacteria, fungi, yeasts, viruses and the like.
  • For this purpose, the surface treatment comprises the act of cleaning the surface with said composition, or applying said composition to said surface through the act of spraying ultrasound fogging, painting or water dosing.
  • For the purpose of the invention, the term "water dosing" refers herein to the purification of surfaces in installations and/or surfaces of components thereof by addition of said composition to a liquid, such as a cooling liquid, a rinsing liquid or a circulating liquid, wherein said liquid is in contact with the surface to be treated. Surfaces of pools and ponds, as well as surfaces of industrial installations, such as the inside surface of ducts, pumps and filters may be subject to biofilm growth and accumulation of organic waste. Said composition may thus be added to the liquid which is in contact with said surface.
  • For the purpose of the present invention, the term "synbiotic" refers to a combination of a probiotic and a prebiotic.
  • The prebiotic contains one or more from the group consisting of galacto-oligosaccharides, fructo-oligosaccharides and inulin.
  • According to preferred embodiments, the prebiotic is inulin.
  • According to preferred embodiments of the invention, the prebiotic component has a mass fraction which is at least 0.5 mg, preferably at least 1 mg, more preferably at least 10 mg, even more preferably at least 100 mg, and most preferably at least 1g, per kg of the composition. It will be understood that the prebiotic component has a mass fraction which is at most 300 g, preferably at most 200 g, more preferably at most 100 g and most preferably at most 80 g, per kg of the composition.
  • For the purpose of the present invention, the term "probiotic" or "probiotic component" refers to spores of at least one non-pathogenic species of the genus Bacillus.
  • According to the invention, the probiotic component comprises a mixture of spores of Bacillus subtilis, Bacillus licheniformis, Bacillus megaterium and Bacillus amyloliquefaciens. For the mixture comprising spores of Bacillus subtilis, Bacillus licheniformis, Bacillus megaterium and Bacillus amyloliquefaciens, each of said four Bacillus species has a number of spores which is at least 10%, preferably at least 15%, and more preferably at least 20%, with reference to the total number of spores of said four Bacillus spp. in the mixture. Each of said four Bacillus species has a number of spores which is at most 70%, preferably at most 60%, more preferably at most 60%, even more preferably at most 50%, preferably at most 40%, more preferably at most 35%, and most preferably at most 30%, with reference to the total number of spores of said four Bacillus spp. in the mixture. Preferably, spores of said four species are present in substantially or exactly equal amounts in the mixture.
  • According to particular embodiments of the invention, said mixture further comprises Bacillus polymyxa.
  • According to particular embodiments of the invention, said mixture does not comprise Bacillus coagulans.
  • According to preferred embodiments, the total amount of spores in said aforementioned mixtures ranges from 1×106 to 1×1010 per gram of the composition. Such an amount is expressed as cfu (colony-forming units). It is thereby understood that this value refers to the total number of cfu of all the Bacillus spp. together.
  • According to particular embodiments, the probiotic component is a mixture consisting of spores of Bacillus subtilis, Bacillus licheniformis, Bacillus megaterium and Bacillus amyloliquefaciens.
  • The transformation of spores to vegetative cells is the result of absorption of moisture from the surrounding surface or from the biofilm to which the preparation is applied [Knudsen et al. (2015) J. Bacteriol. 19;198(1): 168-77]. This moisture absorption decreases the absolute moisture content of the surface or biofilm, thus exerting an inhibitory action on moisture availability to other microorganisms. The vegetative Bacillus cells produce a variety of extracellular enzymes on surfaces and in biofilm that reduce the amount of organic nutrients on the surface and in biofilm [Priest (1977) Bacteriol. Rev. 41(3): 711-53]. This reduction exerts an inhibitory action on the food availability to other microorganisms via nutrient depletion and the general concept of competitive exclusion [Ragione et al. (2003) Vet. Microbiol. 94(3): 245-56].
  • Treating a surface with a surface treatment composition containing a probiotic component can affect the concentration of unwanted and potentially harmful microorganisms.
  • Such an effect is further optimized by the selection of a mixture the aforementioned four Bacillus spp., i.e. Bacillus subtilis, Bacillus licheniformis, Bacillus megaterium and Bacillus amyloliquefaciens. As these Bacillus spp. have a different rate in germination, therefore also a different concentration distribution over time, a constant presence of the probiotic component on the surface to be treated is assured. Said selection will result in an even more pronounced moisture depletion as well as an optimized diversity of extracellular enzymes.
  • It has now unexpectedly been found that the addition of a prebiotic component to such a composition and the use thereof in e.g. a cleaning product affects the concentration of pathogens on the treated surface even further. The observed effect is twofold. Firstly, the prebiotic component accelerates in time the activity of the probiotic component.
  • Secondly, the combination of a probiotic component and a prebiotic component reduces even further the concentration of pathogens on the treated surface, resulting in a lower concentration of pathogens on the treated surface in comparison with a similar treatment for such a surface without the prebiotic component.
  • The synbiotic surface treatment composition can be used to purify a surface from organic dirt, which may be in the form of a biofilm matrix, as well as to lower the number of other microorganisms such bacteria, viruses, yeasts and fungi. It has been found that the combination of prebiotics with probiotics strengthen the purifying effect of the composition, the prebiotic component thereby seemingly supporting and strengthening the effect of the probiotics on biofilm removal and lowering other micro-organisms.
  • According to embodiments of the invention, the spores of said probiotic component and said at least one prebiotic component are at least partly encapsulated in microcapsules.
  • For the purpose of the invention, microcapsules are particles containing a prebiotic and/or a probiotic. Such capsules are described in US 20120076864 . Advantageously, the composition can be encapsulated in such microcapsules to provide the composition with longer stability/shelf life. Furthermore, after a "free" first part of the probiotic and prebiotic components of the composition, which part was not encapsulated in microcapsules, has already exerted its effect, said microcapsules may provide for a delayed release of a second part of the probiotic and prebiotic components on the surface or in biofilm. As a result thereof, a persistent activity of the composition for up to 6 weeks can be obtained, provided that sufficient friction is present.
  • If the preparation is thereby applied to a surface that suffers from friction (such as human or animal activity (walking, touching) or mechanical activity (interaction with machines or vehicles and the like)), the presence of the microcapsules is an established way of ensuring that the preparation exerts a lasting action.
  • Consequently, it is advantageous to include such microcapsules in the composition for the treatment of a surface where frequent treatment of the surface is not possible.
  • Typically, the microcapsules are composed of a brittle shell comprising a liquid containing the spores. Said shell breaks open due to friction and releases the contents of the capsule. The microcapsules are typically 1 to 300 µm in diameter.
  • According to embodiments of the invention, the shell is composed of a polymer layer, such as a polymer of gelatin, polyurethane, polyolefins, polyamides, polyesters, polysaccharides, silicone resins, epoxy resins, chitosan and aminoplastic resins such as a melamine formaldehyde resin.
  • According to embodiments of the invention, said probiotic and prebiotic components may be present together or separately in a microcapsule. However, said microcapsules may also be provided containing individual bacterial strains.
  • According to embodiments of the invention, the liquid in the capsules is typically non-aqueous, and more specifically is immiscible with water (e.g. an organic oil, a silicone oil, a fluorocarbon, or mixtures thereof).
  • The weight ratio of the shell to the liquid contained therein is typically 1:500 to 1:5000. The outer layer of this shell can contain functional reactive groups for chemical binding.
  • According to embodiments of the invention, up to 10 wt%, 20 wt%, 30 wt%, 50 wt%, or even 75 wt% of the prebiotic and/or probiotic component may be encapsulated in the microcapsules. Microcapsules may be dispersed in a liquid or viscous composition.
  • According to embodiments of the invention, the composition is processed into cleaning products (detergents), or products for spraying, for (ultrasound) fogging, for painting or for water dosing. Such products are typically in liquid form.
  • Furthermore, depending on the type of treatment and surface type in question, the composition may be used as a component in or formulated as: a detergent, a cleaning product, a liquid, an emulsion, a cream, an ointment, a lotion, a gel, an oil, a solution, a trigger spray, an aerosol spray, a powder, or a semi-solid formulation.
  • Advantageously, said composition can be processed in a product for fogging, preferably ultrasound fogging, and combined with a fogging device. An ultrasound fogging device refers herein to a device that uses high-frequency sound vibrations to produce an extra fine water mist that is then expelled to add moisture to the room. It has been found that such an application allows surface treatment of surfaces that cannot be reached by conventional cleaning techniques or that cannot be treated by means of water dosing.
  • Surface treatment compositions for treatment by (ultrasound) fogging and methods therefore, may be particularly interesting for the treatment of HVAC installation surfaces, especially the surface of the inner sides of ducts. It was found that the installation of an ultrasound fogging device in the duct of an air-conditioning installation, said device fogging a surface treatment composition according to the invention had a beneficial influence on the presence of harmful microorganisms.
  • In preferred embodiments, water droplets have an average diameter ranging from 0.5 to 10 µm. It was found that under these conditions, the composition could be maximally distributed into an available space.
  • While the invention has been described hereinabove with reference to specific embodiments, this is done to illustrate and not to limit the invention, the scope of which is defined by the accompanying claims.
  • Experimental Results
  • The invention will be now described in more details with reference to the following examples, whose purpose is merely illustrative and not intended to limit the scope of the invention.
    • Galacto-oligosaccharides: Ergomax GOS
    • Fructo-oligosaccharides: Supersmart Fructo
    • Inulin: Beneo Orafti Inulin
    • Germination speeds as well as cfu count were performed by use of ISO 20391-1:2018.
    Example 1 (E1) - Composition of a synbiotic preparation
  • The surface treatment composition has the following components, per gram of the preparation:
    • 2 × 109 spores of each of the following species: Bacillus subtilis, Bacillus licheniformis, Bacillus megaterium and Bacillus amyloliquefaciens;
    • 50 mg of inulin;
    • 25 mg of galacto-oligosaccharides;
    • 15 mg of fructo-oligosaccharides;
    • 5 mg of microcapsules.
    Comparative Example 2 (CE2) - Composition of a probiotic preparation
  • The surface treatment composition has the following components, per gram of the preparation:
    • 2 × 109 spores of each of the following species: Bacillus subtilis, Bacillus licheniformis, Bacillus megaterium and Bacillus amyloliquefaciens;
    • 5 mg of microcapsules.
    Example 3 (E3) - Effect of a prebiotic component
  • A sample of Example 1 (E1) and a sample of Comparative Example 2 (CE2) were each diluted in water at a 1:100 dilution ratio and then allowed to germinate. Figure 1 shows the germination speed of both samples.
  • From this figure, it can be concluded that germination of the probiotic component occurs more rapidly in a synbiotic formulation. In other words, including a prebiotic component in a product containing a probiotic component results in an increased presence of the probiotic component in the product when evaluated at shorter periods of time.
  • Example 4 (E4) - Comparative Examples 5-6 (CE5-CE6) - Cleaning product
  • An all-purpose cleaning product was defined, having one of the following compositions, as summarized in Table 1: Table 1 - compositions cleaning product
    Component E4 CE5 CE6
    Water 91,8 91,8 91,8
    Sodium Laureth Sulphate 5,5 5,5 5,5
    Probiotic Mixture 1 1 0
    Phenoxyethanol 0,45 0,45 0,45
    Inulin 0,5 0 0
    Galacto-oligosaccharide 0,25 0 0
    Fructo- oligosaccharide 0,15 0 0
    CI 42051 0,05 0,05 0,05
    Fragrance 0,3 0,3 0,3
    Ethanol 0 0 0
    Total weight (g) 100 99,1 98,1
    wherein said components of said cleaning product are expressed in weight and wherein said Probiotic Mixture is an aqueous mixture of Bacillus subtilis, Bacillus licheniformis, Bacillus megaterium and Bacillus amyloliquefaciens. Each component of said probiotic mixture is present in a concentration of 2 × 109 cfu per gram of the total composition, meaning that each component of said mixture has a number of spores which is 25% with reference to the total number of spores.
  • Example 5 (E7) - Purification of a surface
  • Cleaning products according to the composition E4 and CE5 were used to clean stone tile floors of toilets of a confined experimental space under controlled conditions. The stone tile floors were suffering from severe organic pollution and biofilm, mainly in the concrete joints between the tiles. A picture of a stone tile floor before the treatment is shown in Fig. 2A.
  • A first of such floors was cleaned with an all-purpose cleaning product having a composition according to CE5. A second of said stone tile floors was cleaned with an all-purpose cleaning product having a composition according to E4, being a synbiotic composition.
  • Said first and second floor were then cleaned on a daily basis for a period of three weeks, with said cleaning product on the basis of CE5 and E4 respectively.
  • Fig 2B shows the result after three weeks of daily cleaning with the (probiotic) cleaning product having a composition according to CE5. The probiotic cleaning product was capable of removing superficial biofilm on the tiles surface and partly in the joints.
  • Fig. 2C shows the result after three weeks of daily cleaning with the (synbiotic) E4 cleaning product. The synbiotic cleaning product was capable of removing much more organic dirt and biofilm deep into the joints between the tiles, making them bright again at most places, indicating that the addition of a prebiotic component to a probiotic cleaning product has an unexpected invigorative effect.
  • Example 6 (E8) - Purification of a surface
  • All-purpose cleaning products according to the composition E4 (synbiotic composition), CE5 (probiotic composition), and CE6 (forming a diluted detergent) were applied at a daily basis to a floor in a confined experimental space under controlled conditions for a total duration of 10 days. Microbiological samples were taken from the surface of the floor in order to determine the presence of the hospital bacteria Staphylococcus aureus. Such samples were taken after 1, 6, 24, 48, 72, 120 and 240 hours. As of 24 hours, the samples were taken just before product application so as to measure the effect of the previous 24 hours of application.
  • The results in Figure 3 show the following:
    • the application of the diluted detergent ("control" -cleaning product based on composition CE6) does not seem to affect the level of S. aureus CFU's.
    • Applying the probiotic cleaning ("probiotic" - cleaning product based on composition CE5) results in a drop of S. aureus CFU's as of 24 hours in order to reach a minimum level (i.e. 430 cfu/m2) after 240 hours.
    • Applying the synbiotic cleaning product ("synbiotic" - based on composition E4) leads to a faster decrease of S. aureus CFU's resulting in a lower level (i.e. 220 cfu/m2) after 240 hours.
    Example 7 (E9) - Ultrasound fogging of synbiotic preparation
  • The synbiotic preparation as described in E1 was diluted tenfold in water containing 0,1 wt% of Sodium Laureth Sulphate. The dilution was subsequently introduced in an ultrasound fogging device. A Bionaire® BUL9500B-U Warm and Cool Mist Ultrasonic Humidifier device, a commercially available air humidifier, was therefore used.
  • A fog with particles having a diameter being predominantly between 0.8µm and 10µm was generated.
  • The device was placed in one corner of a 120m3 room and sprayed every 15 minutes for 20 seconds, with an output of 1ml of synbiotic solution per minute. Nutrient agar plates were placed on a table at the other side of the room, with open covers. Every 15 minutes, after each fogging, one nutrient agar plate was closed and incubated. A probiotic count was as such determined at starting point (Fig. 4A) and after 15 (Fig. 4B), 30 (Fig. 4C) and 60 (Fig. 4D) minutes.
  • As illustrated by Figs. 4A-4D, a high probiotic count was measured already after 30 minutes, indicating that ultrasound fogging is a very effective distribution of probiotics through the air.

Claims (7)

  1. A method for treating surfaces with a surface treatment composition, said composition comprising spores of non-pathogenic species of the genus Bacillus and a prebiotic component,
    wherein said non-pathogenic species of the genus Bacillus comprises a mixture of Bacillus subtilis, Bacillus licheniformis, Bacillus megaterium and Bacillus amyloliquefaciens, each of said four Bacillus species having a number of spores which is between 10% and 70%, with reference to the total number of spores of said four Bacillus spp,, and
    wherein said prebiotic component comprises at least one of a fructo-oligosaccharide, a galacto-oligosaccharide and/or inulin,
    wherein the surface is wood, paper, leather, rubber or textile; wherein the surface is an abiotic material, or wherein the surface is a mixture of said aforementioned materials;
    said method comprising the steps of cleaning, spraying, ultrasound fogging, painting, or water dosing said surfaces with said composition.
  2. The method according to claim 1, wherein said mixture of said non-pathogenic species is present in a combined concentration of 1 × 106 to 1 × 1010 cfu per gram composition.
  3. The method according to any one of previous claims, wherein said prebiotic component is present in a concentration of 100 mg to 100 g per kg composition.
  4. The method according to any one of previous claims, wherein said spores of said non-pathogenic species and said prebiotic component are at least partly encapsulated in microcapsules.
  5. The method according to claim 4, wherein said microcapsule comprises a brittle shell and is furthermore filled with a non-aqueous solution.
  6. The method according to claim 4 or 5, wherein the diameter of the microcapsules is 1 to 300 µm.
  7. The method according to any one of previous claims, wherein said composition is formulated as a detergent, cleaning product, liquid, emulsion, gel, oil, solution, trigger spray, aerosol spray, powder, or semi-solid formulation.
EP19153404.9A 2019-01-23 2019-01-23 Synbiotic surface treatment composition Active EP3686266B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP19153404.9A EP3686266B1 (en) 2019-01-23 2019-01-23 Synbiotic surface treatment composition
PL19153404.9T PL3686266T3 (en) 2019-01-23 2019-01-23 Composition for synbiotic surface treatment
ES19153404T ES3000886T3 (en) 2019-01-23 2019-01-23 Synbiotic surface treatment composition
PT191534049T PT3686266T (en) 2019-01-23 2019-01-23 Synbiotic surface treatment composition
HUE19153404A HUE069638T2 (en) 2019-01-23 2019-01-23 Synbiotic surface treatment composition
BE20205048A BE1026988B1 (en) 2019-01-23 2020-01-23 Synbiotic composition for surface treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19153404.9A EP3686266B1 (en) 2019-01-23 2019-01-23 Synbiotic surface treatment composition

Publications (2)

Publication Number Publication Date
EP3686266A1 EP3686266A1 (en) 2020-07-29
EP3686266B1 true EP3686266B1 (en) 2024-10-23

Family

ID=65493788

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19153404.9A Active EP3686266B1 (en) 2019-01-23 2019-01-23 Synbiotic surface treatment composition

Country Status (6)

Country Link
EP (1) EP3686266B1 (en)
BE (1) BE1026988B1 (en)
ES (1) ES3000886T3 (en)
HU (1) HUE069638T2 (en)
PL (1) PL3686266T3 (en)
PT (1) PT3686266T (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1031746B1 (en) 2023-06-29 2025-02-05 Pollet Sa Cleaning composition based on probiotic bacteria for the degradation of allergens and/or dust
BG113765A (en) * 2023-08-21 2025-02-28 Иван РАДЕВ Method of preparing a probiotic product for neutralization of allergens released by house dust mites, composition of the product and method of use
EP4559998A1 (en) * 2023-11-22 2025-05-28 The Procter & Gamble Company Composition comprising microcapsules comprising spores
PL448280A1 (en) * 2024-04-11 2025-10-13 Biosphertia Spółka Z Ograniczoną Odpowiedzialnością Bacillus sp. strains for use in the prevention or treatment of diseases caused by the Der p1 allergen

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0245560A1 (en) * 1986-03-20 1987-11-19 Sybron Chemical Industries Inc. Liquid cleaner containing viable microorganisms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716435B1 (en) * 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US6387874B1 (en) * 2001-06-27 2002-05-14 Spartan Chemical Company, Inc. Cleaning composition containing an organic acid and a spore forming microbial composition
BE1016597A6 (en) 2005-05-25 2007-02-06 Gielen Cornelis METHOD FOR KEEPING PATHGENE FREE OF A SURFACE, OBJECT AND / OR DEVICE.
GB0909909D0 (en) 2009-06-09 2009-07-22 Chrisal Nv Microcapsules containing microrgnisms
WO2016022779A1 (en) * 2014-08-06 2016-02-11 Envera, Llc Bacterial spore compositions for industrial uses
BE1023416B1 (en) * 2016-02-26 2017-03-14 Chrisal Nv Synbiotic preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0245560A1 (en) * 1986-03-20 1987-11-19 Sybron Chemical Industries Inc. Liquid cleaner containing viable microorganisms

Also Published As

Publication number Publication date
PT3686266T (en) 2025-01-06
HUE069638T2 (en) 2025-03-28
BE1026988A1 (en) 2020-08-17
PL3686266T3 (en) 2025-03-24
ES3000886T3 (en) 2025-03-03
EP3686266A1 (en) 2020-07-29
BE1026988B1 (en) 2020-08-24

Similar Documents

Publication Publication Date Title
EP3686266B1 (en) Synbiotic surface treatment composition
CN105019236B (en) A kind of textile composite antibacterial finishing agent
CN101669518B (en) Germicidal antiviral composite containing chlorine dioxide
WO2017203440A1 (en) Method for producing microbial probiotic biofilms and uses thereof
JP5046666B2 (en) Antibacterial method and microorganism powder, microorganism-containing liquid agent, microorganism-containing gelling agent
WO1999053915A1 (en) Inhibition of gram positive bacteria
KR102575807B1 (en) The manufacturing method and composition of eco-friendly detergent using spinach, green tea, oyster shell and resin
CN101557838A (en) Sanitary fabric comprising a microbe-inhibiting composition
CA2598203A1 (en) Novel uses of calcium hydroxide
EP3210612B1 (en) Synbiotic preparation
CN101020072B (en) Deodorant, antibacterial, anti-mildew powder
CN107258814A (en) A kind of composite disinfectant of Quick disinfection sterilization and its preparation method and application
JP6347430B2 (en) Microorganism having antibacterial ability and deodorizing ability, and antibacterial agent, deodorant, antibacterial method, and deodorizing method using the same
US7547413B2 (en) Systems and methods for disinfecting and sterilizing by applying steam vapor containing low zeta potential mineral crystals
EP3685669A1 (en) Composition for the decontamination and inoculation of surfaces
EP1283010A1 (en) Compositions based on bacterial complexes and their application for preventing nosocomial infections
KR20170009702A (en) Wet wipes composition and wet wipes containing the same including the troplone
US20240148932A1 (en) Wound dressing with preventive biofilm additive
Muazu et al. Assessment of chemical disinfectants efficacy against Escherichia coli biofilm developed on glass and wood at refrigeration and room temperatures
CN101094896A (en) Novel uses of calcium hydroxide
CN108913620A (en) A kind of anti-mite microbial inoculum and its preparation method and application
Čapla et al. Sanitation process optimalization in relation to the microbial biofilm of Pseudomonas fluorescens
Kucharska et al. Bioactive Composite Materials In
CN110670349A (en) 5-methyl-2-isopropyl phenol micro-nano composition with mite-removing and bacteriostatic activity
HK1240114A1 (en) Synbiotic preparation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210129

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230406

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: HEIQ CHRISAL NV

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20240603

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602019060692

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

P01 Opt-out of the competence of the unified patent court (upc) registered

Free format text: CASE NUMBER: APP_57781/2024

Effective date: 20241022

REG Reference to a national code

Ref country code: PT

Ref legal event code: SC4A

Ref document number: 3686266

Country of ref document: PT

Date of ref document: 20250106

Kind code of ref document: T

Free format text: AVAILABILITY OF NATIONAL TRANSLATION

Effective date: 20241227

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20250131

Year of fee payment: 7

Ref country code: LU

Payment date: 20250128

Year of fee payment: 7

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: HU

Payment date: 20250122

Year of fee payment: 7

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 3000886

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20250303

REG Reference to a national code

Ref country code: GR

Ref legal event code: EP

Ref document number: 20250400078

Country of ref document: GR

Effective date: 20250211

REG Reference to a national code

Ref country code: HU

Ref legal event code: AG4A

Ref document number: E069638

Country of ref document: HU

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250223

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241023

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PT

Payment date: 20250123

Year of fee payment: 7

Ref country code: DE

Payment date: 20250121

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241023

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241023

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20250226

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20250130

Year of fee payment: 7

Ref country code: SE

Payment date: 20250121

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241023

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20250130

Year of fee payment: 7

Ref country code: AT

Payment date: 20250122

Year of fee payment: 7

Ref country code: GR

Payment date: 20250122

Year of fee payment: 7

Ref country code: CH

Payment date: 20250201

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CZ

Payment date: 20250120

Year of fee payment: 7

Ref country code: FR

Payment date: 20250127

Year of fee payment: 7

Ref country code: PL

Payment date: 20250117

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20250128

Year of fee payment: 7

Ref country code: IT

Payment date: 20250130

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250123

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20250117

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241023

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241023

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241023

REG Reference to a national code

Ref country code: DE

Ref legal event code: R026

Ref document number: 602019060692

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241023

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241023

PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

PLAX Notice of opposition and request to file observation + time limit sent

Free format text: ORIGINAL CODE: EPIDOSNOBS2

26 Opposition filed

Opponent name: DEVAN CHEMICALS NV

Effective date: 20250722

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241023

R26 Opposition filed (corrected)

Opponent name: DEVAN CHEMICALS NV

Effective date: 20250722

PLBB Reply of patent proprietor to notice(s) of opposition received

Free format text: ORIGINAL CODE: EPIDOSNOBS3